| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |